ALPRAZOLAM Side Effects

6807326-2 | Balance Disorder, Confusional State, Dizziness, Gait Disturbance
on Oct 15, 2008 Female patient from UNITED STATES , weighting 198.4 lb, was diagnosed with anxiety (What is anxiety?), depression (What is depression?), cardiac disorder and was treated with Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, confusional state, dizziness (What is dizziness?), gait disturbance. Alprazolam dosage: . During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6807025-7 | Hypoaesthesia
Patient was taking Alprazolam (View Usage). Patient had the following side effects: hypoaesthesia on Jul 10, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 199.1 lb, was diagnosed with anxiety (What is anxiety?), panic attack and. Alprazolam dosage: . During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), ANTINEOPLASTIC AGENTS (View Antineoplastic Agents Review and Antineoplastic Agents Label ).

6806891-9 | Asthma, Panic Reaction
Adverse event was reported on Jun 06, 2008 by a Female patient taking Alprazolam (View Usage) (Dosage: ) was diagnosed with anxiety (What is anxiety?), panic attack and. Location: UNITED STATES , weighting 190.5 lb, After Alprazolam was administered, patient had the following side effects: asthma (What is asthma?), panic reaction. During the same period patient was treated with METHADONE (View Methadone Review and Methadone Label ), ZANTAC (View Zantac Review and Zantac Label ).

6806726-4 | Circadian Rhythm Sleep Disorder, Dyspnoea, Feeling Abnormal, Somnolence
on Jun 24, 2008 Female patient from UNITED STATES , weighting 165.3 lb, was diagnosed with anxiety (What is anxiety?), panic attack and was treated with Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: circadian rhythm sleep disorder, dyspnoea, feeling abnormal, somnolence. Alprazolam dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), DUONEB (View Duoneb Review and Duoneb Label ).


6806681-7 | Weight Increased
on Mar 31, 2008 Female patient from UNITED STATES , 56 years of age, weighting 120.3 lb, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Alprazolam (View Usage). Patient had the following side effects: weight increased. Alprazolam dosage: . During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), PROTONIX (View Protonix Review and Protonix Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6806494-6 | Withdrawal Syndrome
Patient was taking Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: withdrawal syndrome on Apr 23, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 114.2 lb, was diagnosed with panic attack and. Alprazolam dosage: . During the same period patient was treated with THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

6806360-6 | Discomfort, Headache, Hypoaesthesia, Neuralgia, Pain, Pruritus, Stress
Adverse event was reported on Apr 03, 2008 by a Male patient taking Alprazolam (View Usage) (Dosage: ) was diagnosed with stress (What is stress?), blood pressure (What is blood pressure?) and. Location: UNITED STATES , weighting 238.1 lb, Patient experienced the following unwanted or unexpected effects: discomfort, headache (What is headache?), hypoaesthesia, neuralgia, pain (What is pain?), pruritus, stress (What is stress?). During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), CRESTOR (View Crestor Review and Crestor Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), NEXIUM (View Nexium Review and Nexium Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6806316-3 | Gastric Disorder, Gastrooesophageal Reflux Disease
on Mar 08, 2008 Female patient from UNITED STATES , weighting 167.4 lb, was diagnosed with anxiety (What is anxiety?) and was treated with Alprazolam (View Usage). Patient had the following side effects: gastric disorder, gastrooesophageal reflux disease. Alprazolam dosage: . During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ).

6806101-2 | Fatigue
on Dec 17, 2007 Male patient from UNITED STATES , 15 years of age, was treated with Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: fatigue. Alprazolam dosage: .

6797586-9 | Atrioventricular Block Second Degree, Refusal Of Treatment By Patient, Sinus Bradycardia
Patient was taking Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree, refusal of treatment by patient, sinus bradycardia on Jun 15, 2010 from UNITED STATES Additional patient health information: Male patient , 23 years of age, . Alprazolam dosage: Oral. During the same period patient was treated with LORTAB (View Lortab Review and Lortab Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

6784672-2 | Atrioventricular Block, Atrioventricular Block Second Degree, Refusal Of Treatment By Patient
Adverse event was reported on Jun 14, 2010 by a Male patient taking Alprazolam (View Usage) (Dosage: ) . Location: UNITED STATES , 23 years of age, Patient had the following side effects: atrioventricular block, atrioventricular block second degree, refusal of treatment by patient. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ).

6782337-4 | Accidental Overdose, Pulmonary Haemorrhage, Pulmonary Oedema
on Jun 09, 2010 Male patient from UNITED STATES , weighting 150.0 lb, was treated with Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: accidental overdose, pulmonary haemorrhage, pulmonary oedema. Alprazolam dosage: Unk. During the same period patient was treated with OXYCODONE (Unk) (View Oxycodone Review and Oxycodone Label ), METHADONE (Unk) (View Methadone Review and Methadone Label ), ETHANOL (Unk) (View Ethanol Review and Ethanol Label ).

6773918-2 | Abasia, Anxiety, Balance Disorder, Blister, Coordination Abnormal, Disturbance In Attention, Dyspnoea, Memory Impairment, Movement Disorder
on Jun 15, 2010 Female patient from UNITED STATES , 77 years of age, weighting 177.0 lb, was diagnosed with death of relative and was treated with Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, anxiety (What is anxiety?), balance disorder, blister, coordination abnormal, disturbance in attention, dyspnoea, memory impairment, movement disorder (What is movement disorder?). Alprazolam dosage: One A Day.

6763916-7 | Arthralgia, Food Allergy
Patient was taking Alprazolam (View Usage). Patient had the following side effects: arthralgia, food allergy (What is food allergy?) on Jun 01, 2010 from UNITED STATES Additional patient health information: Female patient , 78 years of age, . Alprazolam dosage: Unk. During the same period patient was treated with COZAAR (Unk) (View Cozaar Review and Cozaar Label ).

6760582-1 | Nephrolithiasis
Adverse event was reported on May 30, 2010 by a Female patient taking Alprazolam (View Usage) (Dosage: 0.5 Mg, 1x/day) was diagnosed with nervousness, anxiety (What is anxiety?) and. Location: UNITED STATES , weighting 135.0 lb, After Alprazolam was administered, patient had the following side effects: nephrolithiasis.

6758803-4 | Bradyphrenia, Hypokinesia, Sopor
on May 17, 2010 Female patient from ITALY , 61 years of age, was diagnosed with intentional self-injury and was treated with Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: bradyphrenia, hypokinesia, sopor. Alprazolam dosage: 20 Df; Qd Po, 20 Df; Tab; Po; Qd. During the same period patient was treated with TRIAZOLAM (19 Df; Qd Po, 19 Df; Tab; Po; Qd) (View Triazolam Review and Triazolam Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), LITHIUM CARBOANTE (LITHIUM CARBONATE) (View Lithium Carboante (lithium Carbonate) Review and Lithium Carboante (lithium Carbonate) Label ). Patient was hospitalized.

6753118-2 | Lymphopenia, Neutropenia, Thrombocytopenia
on May 21, 2010 Male patient from FRANCE , 77 years of age, was diagnosed with abnormal behaviour, dementia alzheimer's type, hypertension, ischaemic heart disease prophylaxis and was treated with Alprazolam (View Usage). Patient had the following side effects: lymphopenia, neutropenia, thrombocytopenia. Alprazolam dosage: 0.25 Mg, Unk. During the same period patient was treated with ARICEPT (10 Mg, 1x/day) (View Aricept Review and Aricept Label ), MEMANTINE HYDROCHLORIDE (10 Mg, 1x/day) (View Memantine Hydrochloride Review and Memantine Hydrochloride Label ), CORGARD (80 Mg, 1x/day) (View Corgard Review and Corgard Label ), KARDEGIC (1 Df, 1x/day) (View Kardegic Review and Kardegic Label ), HALDOL (20 Gtt, 2x/day) (View Haldol Review and Haldol Label ), EQUANIL (800 Mg, Unk) (View Equanil Review and Equanil Label ). Patient was hospitalized.

6751928-9 | Balance Disorder, Cardiac Disorder, Diarrhoea, Dizziness, Flatulence, Gastrointestinal Disorder, Gastrointestinal Pain, Hypersensitivity
Patient was taking Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: balance disorder, cardiac disorder, diarrhoea, dizziness (What is dizziness?), flatulence, gastrointestinal disorder, gastrointestinal pain, hypersensitivity on May 21, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 162.0 lb, was diagnosed with anxiety (What is anxiety?), insomnia, depression (What is depression?), thyroid disorder and. Alprazolam dosage: 1/2 Of 0.25 Mg Dose Daily. During the same period patient was treated with SOLU MEDROL (Unk) (View Solu-medrol Review and Solu-medrol Label ), DOCUSATE SODIUM (Unk) (View Docusate Sodium Review and Docusate Sodium Label ), LEVOTHYROXINE SODIUM (50 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6744429-5 | Obesity
Adverse event was reported on May 19, 2010 by a Male patient taking Alprazolam (View Usage) (Dosage: Unk) . Location: UNITED STATES , weighting 266.0 lb, Patient experienced the following unwanted or unexpected effects: obesity (What is obesity?). During the same period patient was treated with OXYCODONE (Unk) (View Oxycodone Review and Oxycodone Label ).

6737893-9 | Respiratory Depression, Sedation, Unresponsive To Stimuli
on May 21, 2010 Male patient from UNITED STATES , 64 years of age, was diagnosed with anxiety (What is anxiety?), pain (What is pain?) and was treated with Alprazolam (View Usage). Patient had the following side effects: respiratory depression, sedation, unresponsive to stimuli. Alprazolam dosage: 1 Mg Tid Po. During the same period patient was treated with MORPHINE (30 Mg Other Po) (View Morphine Review and Morphine Label ). Patient was hospitalized.

6726189-7 | Balance Disorder, Cardiac Disorder, Diarrhoea, Dizziness, Flatulence, Gastrointestinal Disorder, Gastrointestinal Pain, Hypersensitivity
on May 04, 2010 Male patient from UNITED STATES , weighting 162.0 lb, was diagnosed with anxiety (What is anxiety?), insomnia, depression (What is depression?), thyroid disorder and was treated with Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: balance disorder, cardiac disorder, diarrhoea, dizziness (What is dizziness?), flatulence, gastrointestinal disorder, gastrointestinal pain, hypersensitivity. Alprazolam dosage: 1/2 Of 0.25 Mg Dose Daily. During the same period patient was treated with SOLU MEDROL (Unk) (View Solu-medrol Review and Solu-medrol Label ), DOCUSATE SODIUM (Unk) (View Docusate Sodium Review and Docusate Sodium Label ), LEVOTHYROXINE SODIUM (50 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6719671-X | Thinking Abnormal
Patient was taking Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: thinking abnormal on May 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 140.2 lb, was diagnosed with panic disorder (What is panic disorder?) and. Alprazolam dosage: 1 Mg Daily 047.

6713884-9 | Aphthous Stomatitis, Oesophageal Pain, Reaction To Azo-dyes
Adverse event was reported on Apr 30, 2010 by a Female patient taking Alprazolam (View Usage) (Dosage: 2 Mg, 2x/day) was diagnosed with anxiety (What is anxiety?) and. Location: UNITED STATES , weighting 97.00 lb, Patient had the following side effects: aphthous stomatitis, oesophageal pain, reaction to azo-dyes. During the same period patient was treated with TRAZODONE (Unk) (View Trazodone Review and Trazodone Label ).

6712026-3 | Activities Of Daily Living Impaired, Arthralgia, Dysarthria, Weight Increased
on Apr 28, 2010 Female patient from UNITED STATES , weighting 160.0 lb, was diagnosed with panic attack, bipolar disorder (What is bipolar disorder?), depression (What is depression?) and was treated with Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: activities of daily living impaired, arthralgia, dysarthria, weight increased. Alprazolam dosage: 2 Mg, Qd2sdo. During the same period patient was treated with GEODON (80 Mg, Qd) (View Geodon Review and Geodon Label ), ABILIFY (Unk) (View Abilify Review and Abilify Label ), TOPAMAX (View Topamax Review and Topamax Label ), CONCERTA (54 Mg, Qd) (View Concerta Review and Concerta Label ), LAMICTAL (75 Mg, Qd) (View Lamictal Review and Lamictal Label ).

6710215-5 | Fall
on Apr 22, 2010 Female patient from FRANCE , 89 years of age, was treated with Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?). Alprazolam dosage: Unk. During the same period patient was treated with OLMESARTAN MEDOXOMIL (Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ALISKIREN (Unk) (View Aliskiren Review and Aliskiren Label ), IXPRIM (Unk) (View Ixprim Review and Ixprim Label ), VASTAREL (View Vastarel Review and Vastarel Label ). Patient was hospitalized.

6697778-3 | Aneurysm, Asthenia, Blood Chloride Decreased, Blood Potassium Decreased, Cholestasis, Cushing's Syndrome, Decreased Appetite, Dyskinesia, Fall
Patient was taking Alprazolam (View Usage). Patient had the following side effects: aneurysm (What is aneurysm?), asthenia, blood chloride decreased, blood potassium decreased, cholestasis, cushing's syndrome, decreased appetite, dyskinesia, fall (What is fall?) on Apr 13, 2010 from FRANCE Additional patient health information: Female patient , 77 years of age, weighting 97.00 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), polyarthritis and. Alprazolam dosage: 0.625 Mg, Daily, Oral. During the same period patient was treated with CAPTOPRIL (CAPTOPRIL) TABLET (50 Mg, Bid, Oral) (View Captopril (captopril) Tablet Review and Captopril (captopril) Tablet Label ), CARBIDOPA/LEVODOPA (CARBIDOPA, LEVODOPA) TABLET (1 Df Tid 200-20 Mg, Oral) (View Carbidopa/levodopa (carbidopa, Levodopa) Tablet Review and Carbidopa/levodopa (carbidopa, Levodopa) Tablet Label ), HYDROCHLOROTHIAZIDE (25 Mg, Bid, Oral) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), AMOXICILLIN/CLAVULANATE POTASSIUM (AMOXICILLIN TRIHYDRATE, CLAVULANATE (1000 Mg, Tid, Oral) (View Amoxicillin/clavulanate Potassium (amoxicillin Trihydrate, Clavulanate Review and Amoxicillin/clavulanate Potassium (amoxicillin Trihydrate, Clavulanate Label ), PREDNISONE TAB (50 Mg, Daily, Then Dosage Progressively Decreased, Oral) (View Prednisone Tab Review and Prednisone Tab Label ), NEBIVOLOL HCL (5 Mg, Daily, Oral) (View Nebivolol Hcl Review and Nebivolol Hcl Label ), OMEPRAZOLE (40 Mg, Daily, Oral) (View Omeprazole Review and Omeprazole Label ), AMLODIPINE (5 Mg, Daily, Oral) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6694057-5 | Serotonin Syndrome
Adverse event was reported on Apr 12, 2010 by a Male patient taking Alprazolam (View Usage) (Dosage: 1 Mg, 3x/day Prn) . Location: UNITED STATES , 41 years of age, After Alprazolam was administered, patient had the following side effects: serotonin syndrome. During the same period patient was treated with AMLODIPINE BESILATE (5 Mg Daily) (View Amlodipine Besilate Review and Amlodipine Besilate Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), SERTRALINE HCL (50 Mg Daily) (View Sertraline Hcl Review and Sertraline Hcl Label ), VENLAFAXINE HYDROCHLORIDE (300 Mg Daily) (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), MELOXICAM (15 Mg, 2x/day) (View Meloxicam Review and Meloxicam Label ), FAMOTIDINE (20 Mg, 2x/day) (View Famotidine Review and Famotidine Label ), OXYCODONE (20 Mg Daily) (View Oxycodone Review and Oxycodone Label ), CYCLOBENZAPRINE (10 Mg, 3x/day Prn) (View Cyclobenzaprine Review and Cyclobenzaprine Label ). Patient was hospitalized.

6687191-7 | Balance Disorder, Cardiac Disorder, Diarrhoea, Dizziness, Flatulence, Gastrointestinal Pain, Irritability, Muscle Spasms
on Apr 07, 2010 Male patient from UNITED STATES , weighting 160.0 lb, was diagnosed with anxiety (What is anxiety?), insomnia, depression (What is depression?), thyroid disorder and was treated with Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, cardiac disorder, diarrhoea, dizziness (What is dizziness?), flatulence, gastrointestinal pain, irritability, muscle spasms. Alprazolam dosage: 1/2 Of 0.25 Mg Dose Daily. During the same period patient was treated with LEVOTHYROXINE SODIUM (50 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6677280-5 | Bradyphrenia, Hypokinesia, Intentional Overdose, Intentional Self-injury, Sopor
on Mar 26, 2010 Female patient from ITALY , 61 years of age, was diagnosed with intentional self-injury and was treated with Alprazolam (View Usage). Patient had the following side effects: bradyphrenia, hypokinesia, intentional overdose, intentional self-injury, sopor. Alprazolam dosage: 20 Df;tab;po;qd. During the same period patient was treated with TRIAZOLAM (19 Df;tab;po;qd) (View Triazolam Review and Triazolam Label ), VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDRCHLORIDE) (View Venlafaxine Hydrochloride (venlafaxine Hydrchloride) Review and Venlafaxine Hydrochloride (venlafaxine Hydrchloride) Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

6671889-0 | Abdominal Discomfort, Coeliac Disease, Diarrhoea, Flatulence
Patient was taking Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: abdominal discomfort, coeliac disease, diarrhoea, flatulence on Mar 26, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 145.5 lb, was diagnosed with anxiety (What is anxiety?), blood cholesterol increased, micturition disorder, blood pressure abnormal and. Alprazolam dosage: 0.25 Mg, Two And A Half Tablets, Daily. During the same period patient was treated with LIPITOR (10 Mg, 1x/day) (View Lipitor Review and Lipitor Label ), TAMSULOSIN HYDROCHLORIDE (4 Mg, 1x/day) (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), VASOTEC (5 Mg, 2x/day) (View Vasotec Review and Vasotec Label ).

6667008-7 | Disorientation, Dizziness, Dysphagia, Ear Discomfort, Feeling Abnormal, Formication, Hyperhidrosis, Memory Impairment, Monoplegia
Adverse event was reported on Apr 02, 2010 by a Male patient taking Alprazolam (View Usage) (Dosage: .25 Mg 2-3x Daily Po) was diagnosed with insomnia, detoxification and. Location: UNITED STATES , 38 years of age, weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: disorientation, dizziness (What is dizziness?), dysphagia, ear discomfort, feeling abnormal, formication, hyperhidrosis, memory impairment, monoplegia. During the same period patient was treated with CLONAZEPAM (1 Mg Taper 1xday Done May Po) (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

6666394-1 | Panic Attack, Sensory Disturbance
on Mar 22, 2010 Male patient from UNITED STATES , weighting 221.0 lb, was diagnosed with supraventricular extrasystoles and was treated with Alprazolam (View Usage). Patient had the following side effects: panic attack, sensory disturbance. Alprazolam dosage: 2 Mg. During the same period patient was treated with METOPROLOL (Unk) (View Metoprolol Review and Metoprolol Label ), HYDROCHLOROTHIAZIDE (25 Mg) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SIMVASTATIN (40 Mg) (View Simvastatin Review and Simvastatin Label ), ACETYLSALICYLIC ACID ENTERIC COATED (Unk) (View Acetylsalicylic Acid Enteric Coated Review and Acetylsalicylic Acid Enteric Coated Label ), FISH OIL (Unk) (View Fish Oil Review and Fish Oil Label ).

6654454-0 | Abdominal Pain, Anaemia, Anxiety, Chest Pain, Confusional State, Constipation, Fatigue, Feeling Jittery, Gait Disturbance
on Mar 17, 2010 Female patient from UNITED STATES , 76 years of age, was treated with Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, anxiety (What is anxiety?), chest pain (What is chest pain?), confusional state, constipation (What is constipation?), fatigue, feeling jittery, gait disturbance. Alprazolam dosage: . During the same period patient was treated with VENLAFAXINE HYDROCHLORIDE (NGX) (View Venlafaxine Hydrochloride (ngx) Review and Venlafaxine Hydrochloride (ngx) Label ), ZOLPIDEM TARTRATE (NGX) (View Zolpidem Tartrate (ngx) Review and Zolpidem Tartrate (ngx) Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), MACROGOL (View Macrogol Review and Macrogol Label ), DASATINIB (70 Mg, Qd) (View Dasatinib Review and Dasatinib Label ). Patient was hospitalized.

6654023-2 | Extrapyramidal Disorder, Suicidal Ideation
Patient was taking Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder, suicidal ideation on Mar 15, 2010 from GREECE Additional patient health information: Female patient , 52 years of age, . Alprazolam dosage: 1.5mg Daily. During the same period patient was treated with FLUOXETINE (60 Mg/day) (View Fluoxetine Review and Fluoxetine Label ).

6648248-X | Abdominal Pain, Anaemia, Anxiety, Asthenia, Condition Aggravated, Confusional State, Constipation, Escherichia Urinary Tract Infection, Fatigue
Adverse event was reported on Mar 05, 2010 by a Female patient taking Alprazolam (View Usage) (Dosage: ) . Location: DENMARK , 76 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, anxiety (What is anxiety?), asthenia, condition aggravated, confusional state, constipation (What is constipation?), escherichia urinary tract infection, fatigue. During the same period patient was treated with OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), MACROGOL (View Macrogol Review and Macrogol Label ), DASATINIB (View Dasatinib Review and Dasatinib Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6642436-4 | Kidney Enlargement
on Mar 12, 2010 Male patient from SLOVAKIA (Slovak Republic) , weighting 7.72 lb, was treated with Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: kidney enlargement. Alprazolam dosage: 0.25 Mg, 1x/day.

6626032-0 | Activities Of Daily Living Impaired, Back Pain, Dizziness, Ear Pain, Gastric Ulcer, Headache, Malaise, Nausea, Neuralgia
on Feb 24, 2010 Female patient from JAPAN , 40 years of age, weighting 110.2 lb, was treated with Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, back pain (What is back pain?), dizziness (What is dizziness?), ear pain, gastric ulcer, headache (What is headache?), malaise, nausea (What is nausea?), neuralgia. Alprazolam dosage: . During the same period patient was treated with LIDOCAINE HYDROCHLORIDE (View Lidocaine Hydrochloride Review and Lidocaine Hydrochloride Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), KETAMINE HYDROCHLORIDE (10 Mg, As Needed) (View Ketamine Hydrochloride Review and Ketamine Hydrochloride Label ), CARBAMAZEPINE (200 Mg, 1x/day) (View Carbamazepine Review and Carbamazepine Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), MEXILETINE (View Mexiletine Review and Mexiletine Label ), ETODOLAC (View Etodolac Review and Etodolac Label ).

6616255-9 | Intentional Overdose, Torsade De Pointes
Patient was taking Alprazolam (View Usage). Patient had the following side effects: intentional overdose, torsade de pointes on Feb 23, 2010 from UNITED STATES Additional patient health information: Female patient , 53 years of age, was diagnosed with intentional overdose and. Alprazolam dosage: Unk. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (Unk) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), VERAPAMIL HYDROCHLORIDE (WATSON LABORATORIES) (Unk) (View Verapamil Hydrochloride (watson Laboratories) Review and Verapamil Hydrochloride (watson Laboratories) Label ). Patient was hospitalized.

6614737-7 | Completed Suicide
Adverse event was reported on Feb 19, 2010 by a Female patient taking Alprazolam (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, After Alprazolam was administered, patient had the following side effects: completed suicide. During the same period patient was treated with FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PROPAFENONE HCL (View Propafenone Hcl Review and Propafenone Hcl Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6614325-2 | Chest Pain, Constipation, Malaise
on Feb 18, 2010 Male patient from FRANCE , 77 years of age, was treated with Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), constipation (What is constipation?), malaise. Alprazolam dosage: . Patient was hospitalized.

6614324-0 | Chest Pain, Constipation, Malaise
on Feb 18, 2010 Male patient from FRANCE , 77 years of age, was treated with Alprazolam (View Usage). Patient had the following side effects: chest pain (What is chest pain?), constipation (What is constipation?), malaise. Alprazolam dosage: . Patient was hospitalized.

6612911-7 | Cardio-respiratory Arrest
Patient was taking Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: cardio-respiratory arrest on Feb 19, 2010 from UNITED STATES Additional patient health information: Female patient , 58 years of age, . Alprazolam dosage: . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SECOBARBITAL SODIUM (View Secobarbital Sodium Review and Secobarbital Sodium Label ), CARISOPRODOL (View Carisoprodol Review and Carisoprodol Label ), MORPHINE (View Morphine Review and Morphine Label ).

6612833-1 | Cardiac Arrest, Respiratory Arrest
Adverse event was reported on Jan 04, 2010 by a Male patient taking Alprazolam (View Usage) (Dosage: ) . Location: UNITED STATES , 41 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), respiratory arrest. During the same period patient was treated with ACETAMINOPHEN W/DIPHENHYDRAMINE (View Acetaminophen W/diphenhydramine Review and Acetaminophen W/diphenhydramine Label ), COCAINE (View Cocaine Review and Cocaine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ).

6611189-8 | Influenza, Insomnia, Malaise, Nervousness, Product Quality Issue
on Mar 01, 2010 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with anxiety (What is anxiety?), panic disorder with agoraphobia and was treated with Alprazolam (View Usage). Patient had the following side effects: influenza, insomnia, malaise, nervousness, product quality issue. Alprazolam dosage: 1 Mg 3 Times A Day.

6610502-5 | Electrocardiogram Qt Prolonged, Intentional Overdose, Torsade De Pointes
on Feb 16, 2010 Female patient from UNITED STATES , 53 years of age, was diagnosed with intentional overdose and was treated with Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: electrocardiogram qt prolonged, intentional overdose, torsade de pointes. Alprazolam dosage: . During the same period patient was treated with CITALOPRAM (View Citalopram Review and Citalopram Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

6610489-5 | Electrocardiogram Qt Prolonged, Intentional Overdose, Torsade De Pointes
Patient was taking Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, intentional overdose, torsade de pointes on Feb 16, 2010 from UNITED STATES Additional patient health information: Female patient , 53 years of age, was diagnosed with intentional overdose and. Alprazolam dosage: . During the same period patient was treated with CITALOPRAM (View Citalopram Review and Citalopram Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

6610488-3 | Electrocardiogram Qt Prolonged, Intentional Overdose, Torsade De Pointes
Adverse event was reported on Feb 16, 2010 by a Female patient taking Alprazolam (View Usage) (Dosage: ) was diagnosed with intentional overdose and. Location: UNITED STATES , 53 years of age, Patient had the following side effects: electrocardiogram qt prolonged, intentional overdose, torsade de pointes. During the same period patient was treated with CITALOPRAM (View Citalopram Review and Citalopram Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

6602755-4 | Intentional Overdose, Torsade De Pointes
on Feb 12, 2010 Female patient from UNITED STATES , 53 years of age, was treated with Alprazolam (View Usage). After Alprazolam was administered, patient had the following side effects: intentional overdose, torsade de pointes. Alprazolam dosage: . During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

6598090-3 | Intentional Overdose, Torsade De Pointes
on Feb 11, 2010 Female patient from UNITED STATES , 53 years of age, was treated with Alprazolam (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose, torsade de pointes. Alprazolam dosage: . During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

6597190-1 | Coeliac Disease, Dehydration, Fibromyalgia, Lyme Disease, Vomiting, Weight Decreased
Patient was taking Alprazolam (View Usage). Patient had the following side effects: coeliac disease, dehydration, fibromyalgia, lyme disease, vomiting, weight decreased on Feb 11, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with panic attack, anxiety (What is anxiety?) and. Alprazolam dosage: Unk.